Learning About Lowering LDL-C

"Elevated LDL-C is directly associated with the development of ASCVD. Learn about current treatments, barriers in applying guideline-directed therapies, strategies for prioritizing LDL-C in clinical practice, combatting misinformation, and utilizing shared decision-making from guests Kim Prado, DNP, AGPCNP-BC, and Binu Koirala, PhD, MGS, RN, FAAN, FPCNA.
2018 Guideline for the Management of Blood Cholesterol: www.ahajournal...
2022 ACC Expert Consensus Decision Pathway on Role of Nonstatin Therapies for LDL-C Lowering in the Management of ASCVD Risk: www.jacc.org/d...
Evolving Management of LDL-C: www.ahajournal...
Shared Decision-Making and Cardiovascular Health: www.ahajournal...
JUPITER Trial: www.ahajournal...
ASTEROID Trial: jamanetwork.co...